Stock A293480 HANA PHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Hana Pharm Co., Ltd.

Equities

A293480

KR7293480000

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
12,560 KRW -0.95% Intraday chart for Hana Pharm Co., Ltd. -1.49% -9.96%
2023 Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore MT
2023 Hyphens Pharma to Develop, Commercialize Hana Pharm's Sedation Drug in Singapore MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Singapore Shares Return to Green; Hyphens Pharma Rises 5% on Deal to Develop Sedation Drug in Singapore
MT
Hyphens Pharma to Develop, Commercialize Hana Pharm's Sedation Drug in Singapore
MT
Hyphens Pharma Pte. Ltd. Signs an Exclusive Sub-License and Supply Agreement with Hana Pharm Co., Ltd. to Develop and Commercialise Byfavo® 20mg in Singapore
CI
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine
MT
Hana Pharm Receives Market Approval for Byfavo (Remimazolam) in Procedural Sedation in South Korea
CI
Hana Pharm Informs PAION AG About the Launch of Byfavo™ (Remimazolam) for the Use in General Anesthesia in South Korea
CI
Hana Pharm Co., Ltd's Equity Buyback announced on August 19, 2019, has expired.
CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.
CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.
CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on August 6, 2019.
CI
Hana Pharm Co., Ltd's Equity Buyback announced on August 6, 2019, has expired with 87,239 shares, representing 0.54% for KRW 1,997.13 million.
CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 9, 2019.
CI
Hana Pharm Co., Ltd's Equity Buyback announced on July 9, 2019, has expired.
CI
Tranche Update on Hana Pharm Co., Ltd's Equity Buyback Plan announced on July 26, 2019.
CI
Hana Pharm Co., Ltd's Equity Buyback announced on July 26, 2019, has expired with 84,312 shares, representing 0.53% for KRW 1,997.08 million.
CI
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.
CI
Hana Pharm Co., Ltd authorizes a Buyback Plan.
CI
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
Hana Pharm Co., Ltd authorizes a Buyback Plan.
CI
Hana Pharm Co., Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A293480 Stock
  4. News Hana Pharm Co., Ltd.